典晶生物医药科技（上海）有限公司 ELUMINEX BIOSCIENCES LIMITED Mediaroom - PR Newswire APAC

Search

典晶生物医药科技（上海）有限公司 ELUMINEX BIOSCIENCES LIMITED

Latest News

Eluminex Biosciences Receives Scientific Recognition for its Recombinant Human Collagen (rhCIII) Biosynthetic Cornea (EB-301) Program to Treat Corneal Blindness

Awarded Honors at the American Society of Cataract and Refractive Surgery (ASCRS) andthe Associatio...

2023-05-16 23:00 1734

Eluminex Biosciences Closes $40+ Million Series B Financing to Continue the Development of Innovative Ophthalmic Assets and Recombinant Human Collagen Technology

SUZHOU, China and SAN FRANCISCO, Feb. 27, 2023 /PRNewswire/ -- Eluminex Biosciences (Suzhou) Limite...

2023-02-28 01:00 1708

Eluminex Biosciences Announces Completion of Initial Enrollment in Part A of the CLARITY Study Evaluating a Human Recombinant Collagen-derived (rhCIII) Biosynthetic Cornea (EB-301)

Initial Part A results to be presented at the upcoming American Society of Cataract and Refractive ...

2023-02-15 01:00 1658

Eluminex Biosciences Acquires Zuretinol Acetate from Retinagenix Holdings

* Purchase of Assets and Related Global Commercialization Rights for Oral 9- cis-Retinol (Zuretino...

2022-01-19 19:49 1237

Eluminex Biosciences, an Ophthalmology-Focused Biotechnology Company, Announces Closing of $50 Million Series A Financing

* Proceeds to fund development of novel and best-in-class therapeutics for eye diseases * Charl...

2020-11-27 21:00 3828